JACC Advances · Nov 17, 2026
Deep Learning With Longitudinal Electrocardiograms Predicts Atrial Fibrillation Better Than a Single Electrocardiogram
By Kwak S, Liu F, Nizam NB et al.
Background Atrial fibrillation (AF) is often paroxysmal and asymptomatic, yet early identification could enable targeted surveillance. Deep learning can predict future AF from a single 12-lead electrocardiogram (ECG), but AF develops through progressive atrial remodeling. Objectives We hypothesized that modeling each patient's longitudinal ECG history would improve 1-year AF prediction over a matched single-ECG model. Methods We developed a transformer-based model that accepts variable-length sequences of prior 12-lead ECGs with time-aware encoding of irregular intervals. We compared it with a single-ECG model sharing the same encoder, covariates, preprocessing, outcome definition, and splits. Models were developed at Weill Cornell Medicine/NewYork-Presbyterian and evaluated on MIMIC-IV-ECG without and with fine-tuning. The outcome was AF documented more than 1 and within 365 days after an index ECG. Discrimination used patient-cluster bootstrapping with 1 random index ECG per patient. Results Cohorts included 107,811 institutional and 55,307 MIMIC-IV-ECG patients. The fine-tuned longitudinal model with age and sex discriminated best (area under the receiver-operating characteristic curve: 0.85; C-index 0.84), exceeding the single-ECG model with age and sex (paired area under the receiver-operating characteristic curve: +0.007; 95% CI: 0.003-0.012; +0.014 with ≥1 prior ECG). Without retraining on MIMIC-IV-ECG, the ECG-only advantage was confined to patients with ≥1 prior ECG (+0.014; 95% CI: 0.004-0.024). After external-domain adaptation, the matched advantage was +0.007 (95% CI: 0.002-0.012). High-risk patients had lower AF-free survival (HR: 8.8; 95% CI: 7.8-10.0). Conclusions A longitudinal deep learning model using serial 12-lead ECGs improved 1-year AF prediction over a matched single-ECG model. Longitudinal ECG modeling may provide a scalable approach to identify patients warranting enhanced AF surveillance.
doi.org/10.1016/j.jacadv.2026.103468PubMed 43038808Biomarkers